News for Sunesis Pharmaceuticals, Inc. - Google Finance

Sunesis Pharmaceuticals, Inc. (SNSS): Hedge Funds Are Bullish and Insiders ...

Tue, 11 Jun 2013 14:56:14 GMT

Sunesis Pharmaceuticals, Inc. (SNSS): Hedge Funds Are Bullish and Insiders ...
Insider Monkey (blog) - Jun 11, 2013

Is Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) a healthy stock for your portfolio? Money managers are turning bullish.

SUNESIS PHARMACEUTICALS INC. : Data and Safety Monitoring Board ...

Thu, 13 Jun 2013 11:31:49 GMT

SUNESIS PHARMACEUTICALS INC. : Data and Safety Monitoring Board ...
4-traders (press release) - Jun 13, 2013

SOUTH SAN FRANCISCO, Calif., June 13, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the independent Data and Safety Monitoring Board (DSMB) for the VALOR trial has completed its latest periodic ...

SUNESIS PHARMACEUTICALS INC. : Sunesis Pharmaceuticals Appoints Steve ...

Tue, 11 Jun 2013 11:21:15 GMT

SUNESIS PHARMACEUTICALS INC. : Sunesis Pharmaceuticals Appoints Steve ...
4-traders (press release) - Jun 11, 2013

SOUTH SAN FRANCISCO, Calif., June 11, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Steve Carchedi has been appointed to the Sunesis Board of Directors, effective immediately.

SUNESIS PHARMACEUTICALS INC. : Sunesis to Present at the Wells Fargo ...

Wed, 12 Jun 2013 19:04:43 GMT

SUNESIS PHARMACEUTICALS INC. : Sunesis to Present at the Wells Fargo ...
4-traders (press release) - Jun 12, 2013

SOUTH SAN FRANCISCO, Calif., June 12, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Eric Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer at Sunesis, ...

SUNESIS PHARMACEUTICALS INC. : Vosaroxin Review Published in Expert ...

Thu, 30 May 2013 11:17:34 GMT

SUNESIS PHARMACEUTICALS INC. : Vosaroxin Review Published in Expert ...
4-traders (press release) - May 30, 2013

"As the authors note, despite new understanding of the biology and genetics of acute myeloid leukemia, outcomes for patients remain poor and the need for new therapies remains urgent," said Adam R. Craig, MD, PhD, Executive Vice President, Development ...

Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference ...

Tue, 21 May 2013 23:23:33 GMT

Sunesis Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference ...
Seeking Alpha - May 21, 2013

Eric H. Bjerkholt - Chief Financial Officer, Principal Accounting Officer, Executive Vice President of Corporate Development & Finance and Corporate Secretary.

Sunesis Pharmaceuticals Inc hires Steve Carchedi to board

Wed, 12 Jun 2013 10:00:41 GMT

Sunesis Pharmaceuticals Inc hires Steve Carchedi to board
MENAFN.COM - Jun 12, 2013

Jun 12, 2013 (Menafn - M2 EQUITYBITES via COMTEX) --Biopharmaceutical company Sunesis Pharmaceuticals Inc (nasdaqcm:SNSS) revealed on Tuesday the addition of Steve Carchedi to its board of directors with immediate effect.

Sunesis to Present at the Wells Fargo 2013 Healthcare Conference

Wed, 12 Jun 2013 22:33:10 GMT

Sunesis to Present at the Wells Fargo 2013 Healthcare Conference
Wall Street Journal - Jun 12, 2013

Should You Buy XOMA Corp (XOMA)?

Mon, 17 Jun 2013 13:05:16 GMT

Should You Buy XOMA Corp (XOMA)?
Insider Monkey (blog) - 17 hours ago

These stocks are NewLink Genetics Corp (NASDAQ:NLNK), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), Repros Therapeutics Inc (NASDAQ:RPRX), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), and Cerus Corporation (NASDAQ:CERS).

TOP GAINERS After Hours Today – Affymax, Groupon, G-III Apparel Group ...

Tue, 04 Jun 2013 12:58:38 GMT

TOP GAINERS After Hours Today – Affymax, Groupon, G-III Apparel Group ...
Pentagon Post - Jun 4, 2013

Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) was trading at $5.38, up 4.5 percent on After-Hours with 5,910 share volume. SNSS was trading -24.83 percent below its 52-week high and 123.91 percent above its 52-week low.

AFTER-HOURS Top Gainers June 3 - Affymax Inc, Groupon Inc, G-III Apparel ... - FxPips.com (blog)